March 2, 2021
Albany, NY

Governor Cuomo Announces Pilot Program Testing the Excelsior Pass at Madison Square Garden and Barclays Center

TOP
Governor Cuomo Announces Pilot Program Testing the Excelsior Pass at Madison Square Garden and Barclays Center
Share

Initial Phase of Pilot Successful During Brooklyn Nets Game at Barclays Center

Excelsior Pass Will Be Tested Again During New York Rangers Game on March 2 at Madison Square Garden

Proven, Secure Technology Will Confirm an Individual's Vaccination or Recent Negative COVID Test; Will Help Fast-Track Reopening Theaters, Stadiums & Other Businesses as More New Yorkers are Vaccinated

Developed in Partnership with IBM

Screenshots of the Excelsior Pass are Available Here

Initiative First Announced in Governor's 2021 State of the State Address

Governor Andrew M. Cuomo today announced a pilot program to test the Excelsior Pass during events at Madison Square Garden and Barclays Center. First announced in the Governor's 2021 State of the State address and developed in partnership with IBM, the Excelsior Pass will use proven, secure technology to confirm an individual's vaccination or a recent negative COVID-19 test through a confidential data transfer to help fast-track the reopening of theaters, stadiums and other businesses in accordance with New York State guidelines. This new technology was successfully tested during the initial phase of the pilot during the Brooklyn Nets game at Barclays Center on February 27. It will now be tested for a second time during the New York Rangers game on March 2 at Madison Square Garden.

Similar to a mobile airline boarding pass, individuals will be able to either print out their pass or store it on their smartphones using the Excelsior Pass's "Wallet App." Each pass will have a secure QR code, which venues will scan using a companion app to confirm someone's COVID health status. The results of the pilot program will be used to enhance the quality of the application, maximizing return on investment and saving development time, prior to submission to Apple and Google for approval to go into their app stores.

"We're doing everything we can to vaccinate as many New Yorkers as possible, as quickly as possible, while keeping the infection rate down and reenergizing our economy in a safe, smart way," Governor Cuomo said. "As we begin reopening the valves on different sectors of our economy, we are putting guidelines in place to ensure individuals attending events involving larger gatherings have tested negative for COVID or have been vaccinated to avoid an outbreak of the virus. The Excelsior Pass will play a critical role in getting information to venues and sites in a secure and streamlined way, allowing us to fast-track the reopening of these businesses and getting us one step closer to reaching a new normal."

While some businesses have been able to operate by reducing capacity or by having their employees work from home, many others, like performing arts and sporting events with fans, which involve large, dense gatherings, have only just been able to re-open under strict health and safety guidelines. As more New Yorkers are being vaccinated, these activities will be permitted to resume in accordance with new public health guidelines, and this new mobile app can help to further fast-track the reopening of these venues.

As part of major stadium and arena reopening guidelines announced by the Governor on February 10, venues must ensure that all staff and spectators receive a negative COVID-19 PCR test within 72 hours of the event. During this pilot program, a subset of predetermined participants will be able to use the pass to confirm their recent negative COVID-19 test and gain entry to these events at Barclays Center and Madison Square Garden.

Robust privacy protections are woven throughout the digital health pass solution, giving individuals a secure, verifiable and trusted way to maintain control of their personal health information using an encrypted digital smartphone wallet or printed credential. Each participant will be able to determine if they would like to use it -and if so, what passes they wish to use for which purpose -all without sharing their underlying personal data. User data is always kept completely confidential, and participation is voluntary. The QR code only informs the venue if a pass is valid or invalid.

Steve LaFleche, General Manager, IBM Public and Federal Market, said, "This solution can provide New York, and other states, a simple, secure, and voluntary method for showing proof of a negative COVID-19 test result or certification of vaccination. IBM is proud to support the State of New York with its efforts to apply innovative technologies to help residents and communities respond to COVID-19."

James Dolan, Executive Chairman, MSG Sports and Executive Chairman and CEO, MSG Entertainment, said, "We are pleased to partner with the state on this important pilot, which we hope will be another step forward in helping New York City to reopen."

John Abbamondi, CEO of BSE Global, said, "We applaud the State for developing the Excelsior Pass, which we believe can help New Yorkers quickly return to venues while keeping them safe from COVID-19. Barclays Center and the Nets are proud to participate in this effort."

The Excelsior Pass and its companion verification app are built on IBM's Digital Health Pass solution and is designed to enable the verification of health credentials such as test results and vaccination records. Using blockchain technology, individuals will be able to voluntarily share their health status through an encrypted digital wallet on their smartphone without the need to share underlying medical and personal information. The technology is flexible and built to scale, allowing other states to join and help foster a safer, trusted transition to a post-pandemic reality.

Translations

বাংলা অনুবাদ
Download
Tradiksyon kreyòl ayisyen
Download
Перевод на русский язык
Download
Traducción al español
Download

Contact the Governor's Press Office

Contact us by phone:

Albany: (518) 474 - 8418
New York City: (212) 681 - 4640